What is a Clinical Study Report (CSR)?

ICH E3 Structure, Regulatory Purpose & Why Quality Writing Matters

Why Clinical Study Reports Matter

A Clinical Study Report (CSR) is one of the most important documents produced in the course of a clinical trial. Required for regulatory submissions such as INDs, BLAs, and NDAs in the US—and by global authorities including the EMA and Health Canada—a CSR presents a comprehensive account of the methods, conduct, and results of a clinical trial.

More than a summary, the CSR must interpret data clearly and objectively, demonstrate adherence to protocol, and provide enough detail to allow regulators to assess the trial's integrity and outcomes. Poorly written CSRs can lead to regulatory questions, delays, or even rejection. High-quality CSR writing is essential for getting your product one step closer to market approval.

What to Know About CSR Requirements

A CSR is required for any interventional clinical trial intended to support a regulatory submission. In the United States, CSRs support Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Biologic License Applications (BLAs). In Europe and other regions, they are included in Marketing Authorization Applications (MAAs).

Regulatory agencies expect CSRs to follow the ICH E3 guideline, which outlines both the structure and level of detail expected in these reports. Compliance with ICH E3 is not optional—it ensures your document includes the context, methodology, and data interpretation regulators need to make informed decisions.

CSR Structure According to ICH E3

The ICH E3 guideline lays out a standardized format for CSRs that includes:

• Title Page and Synopsis
  A concise summary of the trial, including objectives, design, results, and conclusions.

• Table of Contents
  A detailed, organized listing of all included sections and appendices.

• Ethics
  Documentation of ethics committee approvals and informed consent processes.

• Study Administrative Structure
  Describes sponsors, investigators, contract research organizations (CROs), and other involved parties.

• Introduction and Study Objectives
  Clearly defined study rationale and primary/secondary objectives.

• Investigational Plan
  Detailed description of trial design, inclusion/exclusion criteria, dosing, and assessments.

• Study Patients
  Demographic and baseline characteristics, patient disposition, protocol deviations.

• Efficacy and Safety Results
  Comprehensive tables and narrative analyses of all relevant data.

• Discussion and Conclusions
  An interpretation of the data, highlighting clinical relevance and limitations.

• Appendices
  Includes the protocol, statistical analysis plan (SAP), sample case report forms, and more.

Adhering to this structure is essential for ensuring your submission is complete and review-ready.

‍

Key Challenges in CSR Development

CSRs can be hundreds of pages long and require the integration of complex data from multiple sources. Common challenges include:

• Aligning data from clinical, statistical, and safety teams

• Ensuring consistency across text, tables, and listings

• Communicating nuanced efficacy and safety results clearly

• Managing iterative reviews from sponsors and stakeholders

• Meeting tight regulatory timelines with minimal revisions

These challenges make it essential to work with experienced medical writers who understand regulatory expectations and have the skill to communicate your study's story with clarity and precision.

‍

GLOBAL’s CSR Writing Services

GLOBAL’s regulatory writing team provides expert support for end-to-end CSR development. Whether you're preparing for a US FDA or EU submission, we help you meet ICH E3 requirements and tell a clear, compelling clinical story. Our services include:

• Full CSR drafting and formatting

• Gap analysis and document remediation

• Integration of biostatistics and clinical data

• Project management and stakeholder coordination

• Response strategy for regulatory feedback

‍

Strategic Compliance Starts with the Right Partner

A well-written CSR does more than document your trial—it builds trust with regulators. Our team of senior writers brings experience across therapeutic areas, trial phases, and global submissions. We help you reduce review cycles, improve quality, and stay on timeline.

Let us help you turn your trial results into a submission-ready report that speaks with clarity, accuracy, and confidence.

‍

Contact us today to learn how our clinical writing team can accelerate your CSR development.

‍